I may add that it is still a convenience for some patients in taking the medicine. Overall good improvement and good for CSl looking after the patients.
News: CSL Csl Behring Receives FDA Approval For Hizentra® (Immune Globulin Subcutaneous <Origin..., page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$264.08 |
Change
8.770(3.44%) |
Mkt cap ! $127.6B | |||
| Open | High | Low | Value | Volume |
| $258.12 | $264.16 | $257.91 | $159.1M | 607.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 74 | $264.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $264.10 | 84 | 3 |
View Market Depth
| Last trade - 13.56pm 22/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |